Weidman walks the long road to get Symplicity Spiral ready to help patients with hypertension

MedtronicTalks

Treść dostarczona przez MedtronicTalks and Tom Salemi. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez MedtronicTalks and Tom Salemi lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.

3y ago 30:45

MP3•Źródło odcinka

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on October 10, 2024 22:11 (1M ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

In this episode, Jason Weidman, SVP and President of Coronary & Renal Denervation at Medtronic, says he’s doing exactly what he set out to do when he became an engineer over 20 years ago, creating lifesaving medical devices. Weidman is leading Medtronic’s push to secure FDA approval for Medtronic Symplicity Spyral™ RDN system, which uses renal denervation to reduce hypertension. Medtronic’s clinical trials of Symplicity have been among the most closely watched - and most difficult to execute - in the industry. Weidman will discuss the challenges while also sharing his reasons for optimism.

47 odcinków

#Tech #MedtronicTalks #Tom Salemi